Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/109735
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Future imaging of atherosclerosis: molecular imaging of coronary atherosclerosis with ¹⁸F positron emission tomography
Other Titles: Future imaging of atherosclerosis: molecular imaging of coronary atherosclerosis with (18)F positron emission tomography
Author: Scherer, D.
Psaltis, P.
Citation: Cardiovascular Diagnosis and Therapy, 2016; 6(4):354-367
Publisher: AME Publishing Company
Issue Date: 2016
ISSN: 2223-3652
2223-3660
Statement of
Responsibility: 
Daniel J. Scherer, Peter J. Psaltis
Abstract: Atherosclerosis is characterized by the formation of complex atheroma lesions (plaques) in arteries that pose risk by their flow-limiting nature and propensity for rupture and thrombotic occlusion. It develops in the context of disturbances to lipid metabolism and immune response, with inflammation underpinning all stages of plaque formation, progression and rupture. As the primary disease process responsible for myocardial infarction, stroke and peripheral vascular disease, atherosclerosis is a leading cause of morbidity and mortality on a global scale. A precise understanding of its pathogenic mechanisms is therefore critically important. Integral to this is the role of vascular wall imaging. Over recent years, the rapidly evolving field of molecular imaging has begun to revolutionize our ability to image beyond just the anatomical substrate of vascular disease, and more dynamically assess its pathobiology. Nuclear imaging by positron emission tomography (PET) can target specific molecular and biological pathways involved in atherosclerosis, with the application of ¹⁸Fluoride PET imaging being widely studied for its potential to identify plaques that are vulnerable or high risk. In this review, we discuss the emergence of ¹⁸Fluoride PET as a promising modality for the assessment of coronary atherosclerosis, focusing on the strengths and limitations of the two main radionuclide tracers that have been investigated to date: 2-deoxy-2-(¹⁸F)fluoro-D-glucose (¹⁸F-FDG) and sodium ¹⁸F-fluoride (¹⁸F-NaF).
Keywords: Coronary artery disease (CAD); coronary vessels; molecular imaging; positron emission tomography (PET); fluorodeoxyglucose F18; cardiac imaging techniques
Rights: © Cardiovascular Diagnosis and Therapy. All rights reserved.
RMID: 0030053776
DOI: 10.21037/cdt.2015.12.02
Grant ID: http://purl.org/au-research/grants/nhmrc/1086796
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.